Single dose vaccine delivery system of tetanus toxoid formulation based on chitosan microspheres

International Journal of Advances in Pharmaceutical Sciences

Volumn 1, Issue 1, 2010, Pages 42-49

  Dineshkumar, B ^b   Dhanaraj, S A ^a   Santhi, K ^a   Vijayan, P ^b   Chandrasekhar, Raghu ^c  

^a AIMST UNIVERSITY   (Malaysia)

^b JSS COLLEGE OF PHARMACY   (India)

^c MANIPAL UNIVERSITY   (India)

Author keywords

Chitosan microspheres; Single shot vaccine; Tetanus toxoid

Indexed keywords

CHITOSAN; GLUTARALDEHYDE; MICROSPHERE; TETANUS TOXOID; TOLUENE;

ADSORPTION; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CROSS LINKING; DRUG DELIVERY SYSTEM; EMULSION; FLOCCULATION; IN VITRO STUDY; NONHUMAN; PARTICLE SIZE; SINGLE DRUG DOSE; SUSTAINED RELEASE FORMULATION;

EID: 79952024330     PISSN: None     EISSN: 09761055     Source Type: Journal    
DOI: 10.5138/ijaps.2010.0976.1055.01004     Document Type: Article

References (18)

1. Galazka AM. The immunological basis for immunization series. Module 3: tetanus. Geneva: World Health Organization, Global programme for vaccines and immunization: expanded programme on immunization. 1993;WHO/EP/GEN/93:13.
2. Aguado M. Future approaches to vaccine development: single-dose vaccine using controlled release delivery system, Vaccine 1993; 11: 596-597.
3. Okada H, Toguchi H. Biodegradable microspheres in drug delivery. Crit Rev Ther Drug Carrier Syst 1995;12: 1-99.
4. Aguado M, Lambert P. Controlled release vaccines: biodegradable polylactide/ployglycolide PL/PG) microspheres as antigen vehicles. Immunology 1992; 84: 113-125.
5. Calvo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ. Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm Res 1997;14: 1431-1436.
6. Remunan-Lopez C, Bodmeier R. Effect of formulation and process variables on the formation of chitosan-gelatin coacervates. Int J Pharm 1996;136: 63-72.
7. Determination of limes flocculation of Diphtheria toxin. Diphtheria toxoid. Diphtheria vaccine and tetanus vaccine. Indian Pharmacopeia; 1996. Volume 2, p. 29-33.
8. Jaganathan KS, Rao YUB, Singh P, Prabakaran D, Gupta S, Jain A, Vyas SP. Development of single dose tetanus toxoid formulation based on polymeric microspheres; comparative studies of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres. Int J Pharm 2005;294: 23-32.
9. Xing DKL, Crane DT, Bolgiano B, Corbel MJ, Jones C, Sesardic D. Physicochemical and immunological studies on the stability of free and microspheres-encapsulated tetanus toxoid in vitro. Vaccine 1996;14: 1205-1213.
10. Johansen P, Merkle HP, Gander B. Physico-chemical and antigenic properties of tetanus and diphtheria toxoids and steps towards improved stability. Biochimica et Biophysica Acta 1998;1425: 425-436.
11. Esparza I, Kissel T. Parameters affecting the immunogenicity of microencapsulated tetanus toxoid. Vaccine 1992;10: 714-720.
12. Raghuvanshi RS, Katare YK, Lalwani K, Ali MM, Singh O, Panda AK. Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants. Int J Pharm 2002;245: 109-121.
13. Johansen P, Corradin G, Merkle HP, Gander B. Release of tetanus toxoid from adjuvants and OLGA microspheres: How experimental set-up and surface adsorption fool the pattern. J Controlled Release 1998;56: 209-217.
14. Sanchez A, Villamayor B, Guo Y, McIver J, Alonso MJ. Formulation strategies for the stabilization of tetanus toxoid in poly (lactide-co-glycolide) microspheres. Int J Pharm 1999; 185: 255-266.
15. Sasiak AB, Bolgiano B, Crane DT, Hockley DJ, Corbel MJ, Sesardic D. Comparison of in viro and in vivo methods to study stability of PLGA microencapsulated tetanus toxoid vaccines. Vaccine 2001;19: 694-705.
16. Johansen P, Tamber H, Merkle HP, Gander B. Diphtheria and tetanus toxoid microencapsulation into conventional and end-group alkylated PLA/PLGAs. Eur J Pharm Biopharm 1999;47: 193-201.
17. Manghi MA, Pasetti MF, Brero ML, Deluchi S, Paola GD, Mathet V, Eriksson PV. Development of an ELISA for measuring the activity of tetanus toxoids in vaccines and comparision with the toxin neutralization test in mice. J Immunol Methods 1994;168: 17-24.
18. Jung T, Koneberg R, Hungerer K.D, Kissel T. Tetanus toxoid microspheres consisting of biodegradable poly(lactic-co-glycolide) and ABA-triblock-copolymers: immune response in mice. Int J Pharm 2002; 234:75-90.